Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Recivit 267microgram sublingual tablets
0407020A0BTADBZ
|
Recivit | Fentanyl | Central Nervous System | No data available |
|
Recivit 400microgram sublingual tablets
0407020A0BTABAZ
|
Recivit | Fentanyl | Central Nervous System | No data available |
|
Recivit 533microgram sublingual tablets
0407020A0BTACBY
|
Recivit | Fentanyl | Central Nervous System | No data available |
|
Recivit 800microgram sublingual tablets
0407020A0BTAEBB
|
Recivit | Fentanyl | Central Nervous System | No data available |
|
Reductil 10mg capsules
0405020S0BBAAAA
|
Reductil | Sibutramine | Central Nervous System | No data available |
|
Reductil 15mg capsules
0405020S0BBABAB
|
Reductil | Sibutramine | Central Nervous System | No data available |
|
Reminyl 12mg tablets
0411000F0BBACAC
|
Reminyl | Galantamine | Central Nervous System | No data available |
|
Reminyl 4mg tablets
0411000F0BBAAAA
|
Reminyl | Galantamine | Central Nervous System | No data available |
|
Reminyl 8mg tablets
0411000F0BBABAB
|
Reminyl | Galantamine | Central Nervous System | No data available |
|
ReQuip tablets follow on pack
0409010H0BBAEAE
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | No data available |
|
ReQuip tablets starter pack
0409010H0BBAFAF
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | No data available |
|
Resolve effervescent granules 8.09g sachets
0407010X0CXAAA0
|
Resolve | Paracetamol combined preparations | Central Nervous System | No data available |
|
Resolve Extra effervescent granules sachets
0407010X0CXABA0
|
Resolve | Paracetamol combined preparations | Central Nervous System | No data available |
|
Retigabine 100mg tablets
0408010AJAAAAAA
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Retigabine 200mg tablets
0408010AJAAABAB
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Retigabine 300mg tablets
0408010AJAAACAC
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Retigabine 400mg tablets
0408010AJAAADAD
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Retigabine 50mg tablets
0408010AJAAAEAE
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Retigabine 50mg tablets and Retigabine 100mg tablets
0408010AJAAAFAF
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Revocon 25mg tablets
0409030C0BEAAAA
|
Revocon | Tetrabenazine | Central Nervous System | No data available |
|
Rewisca 100mg capsules
0408010AEBCAAAD
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 200mg capsules
0408010AEBCAFAF
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 225mg capsules
0408010AEBCAGAI
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 25mg capsules
0408010AEBCABAA
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 300mg capsules
0408010AEBCAHAG
|
Rewisca | Pregabalin | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.